University of Salford Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
University of Edinburgh Featured PhD Programmes

Neuroscience / Neurology (cell therapy) PhD Projects, Programs & Scholarships

We have 13 Neuroscience / Neurology (cell therapy) PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 13 Neuroscience / Neurology (cell therapy) PhD Projects, Programs & Scholarships

PhD saved successfully

A10 dopamine neurons: the missing link in cell therapeutics for Parkinson's disease?

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and degeneration of the nigral dopamine neurons is a key pathological feature of the condition. Read more

Identification of novel cortical interneuron regulators implicated in neuropsychiatric disorders

Despite representing only ~20% of the entire neuronal population in the neocortex, the GABAergic (Gamma-Aminobutyric Acid) inhibitory interneurons play a pivotal role in most cortical functions. Read more

Regulation of asymmetric cell division in brain cancer stem cells

Glioblastoma is the most lethal brain cancer in adults. Its poor prognosis is a result of aggressive tumour growth, therapeutic resistance, and tumour heterogeneity at the cellular and genetic level. Read more

Exosomes as a therapy for glaucoma

This project is fully funded through the generosity of Glaucoma UK.  . What we are looking for. We are seeking an individual who can demonstrate a passion for research, who has some laboratory experience and is keen to forge a career in the eye-research field. Read more

Cancer: 3D model of the brain tumour perivascular niche: developing new approaches to target brain tumours

Aggressive brain tumours have dismal outcomes. Patients with glioblastoma multiforme, or brain metastases arising from tumours in other part of the body such as melanoma and breast cancer, have a median survival of only 14 months when treated with surgery followed by radiation and chemotherapy. Read more

Developing optogenetic therapies for retinal degeneration

Retinal degeneration is the leading cause of blindness in developed countries. The new exciting biological approach of optogenetic therapy in which ectopic expression of photosensitive proteins (photopigments) is used to restore photosensitivity, offers a potential breakthrough for treating these conditions. Read more
  • 1

Filtering Results